Original authors are interviewed to verify the veracity of the ACE Report and provide additional information regarding the study’s findings and methodology.

PeerView

Features the top trending OE Content from your network over the past 30 days.

OE Originals

OE Insights

Videos

OE Plus

7 Ace Reviews

1 OE Recommends

6 OE PeerView

60 OE Ideas

24 OE World Tour NEW

59 OE Perspectives

43 Conferences

156 Exclusive Interviews

CME

SIGNUP

Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.

Search Filters

Date Range

Report Types

ALL

RCT

Condition

Osteoarthrosis(1) Rheumatoid arthritis(1)

Region of the Body

Knee(1)

Specialties

Arthroplasty Foot & Ankle General Orthopaedics Hand & Wrist

Metabolic Disorders Osteoarthritis Pediatric Orthopaedics Peri-Operative Physical Therapy & Rehab Shoulder & Elbow Spine Sports Medicine Trauma Tumour

See all (15)

Emerging Treatments

Cannabis

OE Recommends Topics

Knee OA

Multimedia

Interviews

Journal

Conference Series

Evidence Series

We found 1 results matching your search query

Showing 1 - 1 of 1

Read Ace Report

Increased IV-TXA Dosage Reduces Blood Loss, Improves Pain and Clinical Outcomes in TKA Patients

Arch Orthop Trauma Surg. 2020 Aug-01;():. 10.1007/s00402-020-03442-2

RCT Arthroplasty Appendicular Lower Extremity Knee Tranexamic Acid (TXA) Antifibrinolytic agent Antifibrinolytic agent Rheumatoid arthritis Osteoarthrosis - Hide

Showing 1 - 1 of 1

ACE REPORTS

Arthroplasty Foot & Ankle General Orthopaedics Hand & Wrist Metabolic Disorders Osteoarthritis Pediatric Orthopaedics

Physical Therapy & Rehab Shoulder & Elbow Spine Sports Medicine Trauma Tumor

OE PLUS

ACE Reviews Conference Series Evidence Series Interviews

SERVICES

Pricing Help and Contact Reprints & Permissions

COMPANY

About Process Partners